Tesamorelin
Hormonal
FDA-approved GHRH analog for HIV-associated lipodystrophy. Reduces visceral adipose tissue.
Community
0
Tracking
0
Doses Logged
1mg/day
Common Dose
—
Adverse Rate
All dosages:1mg/day2mg/day
Reported Adverse Effects
No adverse effects reported yet
Community Consensus
No consensus claims yet — be the first to contribute
Literature
No studies linked yet — know of one? Share it in the discussion
Discussion
No discussion yet — be the first to share your experience